Illumina Tells PTAB To Invalidate Columbia Univ. DNA Patent
By Matt Bernardini ( March 5, 2019, 7:14 PM EST) -- A biotech company told the U.S. Patent Trial and Appeal Board during oral arguments Tuesday that a Columbia University DNA sequencing patent should be ruled invalid due to obviousness and because the board invalidated a similar patent a few years ago....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.